by admin | Nov 26, 2025 | News & Opinions
By Jonah Feldman, Frederick Locke, MD – Targeted Oncology – On June 26, 2025, the FDA announced the elimination of the Risk Evaluation and Mitigation Strategy (REMS) program that applied to 6 chimeric antigen receptor (CAR) T-cell therapies approved to...
by admin | Nov 25, 2025 | News & Opinions
By Paul Knoepfler – STAT – The company that claimed to revive the dire wolf continues to raise ethical questions De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring animal cloning firm Viagen. The same day, retired NFL all-star...
by admin | Nov 24, 2025 | News & Opinions
By Medical Life Sciences News – Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases. SwRI scientists used the...
by admin | Nov 21, 2025 | News & Opinions
By Optics.org – A project at the Technical University of Munich (TUM) has successfully stimulated stem cells in a manner that reliably induced them to develop into bone cells. The technology could ultimately lead to ways to generate specific cells for biomedical...
by admin | Nov 20, 2025 | News & Opinions
by GOAI -Gene Online – Japanese researchers are exploring a novel, minimally invasive method to repair spinal fractures using body fat-derived cells. The experimental approach involves converting fat cells into bone tissue, offering a potential alternative to...
